Reckitt Benckiser stock holds firm as analysts lift targets

Reckitt Benckiser stock is steady near GBX 5,132 as the latest consensus points to GBX 62.34 and July 29, 2026 earnings showed $101.40 EPS.

Shares stay near recent levels

Reckitt Benckiser Group plc (GB00B24CGK77) is trading around GBX 5,132, with a 52-week range of GBX 3,866 to GBX 6,522.92 and a market value of £32.59 billion as of August 28, 2026. The same snapshot shows a 0.00% move on the session and volume of 167.31 million shares.

The latest earnings note in the market data points to July 29, 2026, when the company reported $101.40 EPS for the quarter and trailing net margin of 21.09%. That combination leaves the shares at 11.62 times earnings, below the Consumer Staples sector average of 13.63.

Consensus still leans higher

Analyst positioning remains constructive, with a consensus rating of Hold, 19 analysts on coverage, and an average target of GBX 62.34. The same consensus data set shows a low target of GBX 53.52 and a high target of GBX 75.00, which leaves the average target 21.47% above the last close.

That spread matters because the share price has already fallen 14.5% from GBX 6,002 at the start of the year, so even modest estimate changes can move sentiment. MarketBeat also lists a dividend yield of 4.23% and a payout ratio of 48.84%, which keeps the income case visible beside the valuation debate.

Brands still carry the story

Reckitt still leans on names such as Dettol, Lysol, Durex, Finish, Harpic, Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils. The company says more than 30 million products are sold each day worldwide, which helps explain why investors still focus on margin resilience rather than only headline sales growth.

For context, the market data page pegs trailing return on equity at 42.87% and book value at GBX 1,140.68 per share. That contrast between a rich operating return and a lower valuation multiple is one reason the stock keeps drawing analyst attention.

Reckitt Benckiser stock and the next setup

The most recent consensus data points to a market that still values Reckitt as a defensive consumer staple with room for rerating if the next report confirms stable margins and cash generation. The stock trades on the London market under LON:RKT, with the current market snapshot anchoring the discussion on August 28, 2026.

More on Reckitt Benckiser stock: the key numbers now are GBX 5,132, a 52-week band of GBX 3,866 to GBX 6,522.92, and an average target of GBX 62.34.

Fact box

Company: Reckitt Benckiser Group plc

ISIN: GB00B24CGK77

Ticker: RKT

Exchange: London Stock Exchange

Market cap: £32.59 billion

Sector / Industry: Consumer Staples / Household Products

Index membership: FTSE 100

More on Reckitt Benckiser stock

Dettol and Lysol remain central consumer brands for Reckitt, alongside Durex, Finish, Nurofen and Strepsils.